These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1443119)

  • 1. Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition.
    Abassi ZA; Tate J; Hunsberger S; Klein H; Trachewsky D; Keiser HR
    Am J Physiol; 1992 Nov; 263(5 Pt 1):E870-6. PubMed ID: 1443119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade.
    Barclay PL; Bennett JA; Greengrass PM; Griffin A; Samuels GM; Shepperson NB
    Biochem Pharmacol; 1992 Sep; 44(6):1013-22. PubMed ID: 1417928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
    Seymour AA; Norman JA; Asaad MM; Fennell SA; Abboa-Offei B; Little DK; Kratunis VJ; Delaney NG; Hunt JT; Di Donato G
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1002-9. PubMed ID: 1826031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats.
    Chiu PJ; Tetzloff G; Romano MT; Foster CJ; Sybertz EJ
    Am J Physiol; 1991 Jan; 260(1 Pt 2):R208-16. PubMed ID: 1847022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance receptor and neutral endopeptidase-mediated metabolism of atrial natriuretic factor.
    Okolicany J; McEnroe GA; Koh GY; Lewicki JA; Maack T
    Am J Physiol; 1992 Sep; 263(3 Pt 2):F546-53. PubMed ID: 1415584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and systemic effects of urodilatin in rats with high-output heart failure.
    Abassi ZA; Powell JR; Golomb E; Keiser HR
    Am J Physiol; 1992 Apr; 262(4 Pt 2):F615-21. PubMed ID: 1533100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance function of type C receptors of atrial natriuretic factor in rats.
    Almeida FA; Suzuki M; Scarborough RM; Lewicki JA; Maack T
    Am J Physiol; 1989 Feb; 256(2 Pt 2):R469-75. PubMed ID: 2537040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the renal effects of urodilatin and atrial natriuretic factor: effect of changes in sodium status.
    Yates NA; McDougall JG
    Exp Nephrol; 1994; 2(5):281-5. PubMed ID: 7812733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men.
    Saxenhofer H; Raselli A; Weidmann P; Forssmann WG; Bub A; Ferrari P; Shaw SG
    Am J Physiol; 1990 Nov; 259(5 Pt 2):F832-8. PubMed ID: 2146885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor.
    Margulies KB; Cavero PG; Seymour AA; Delaney NG; Burnett JC
    Kidney Int; 1990 Jul; 38(1):67-72. PubMed ID: 2143548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and action of urodilatin infusion in healthy volunteers.
    Carstens J; Jensen KT; Pedersen EB
    Clin Pharmacol Ther; 1998 Jul; 64(1):73-86. PubMed ID: 9695722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance mechanisms of atrial and brain natriuretic peptides in rats.
    Hashimoto Y; Nakao K; Hama N; Imura H; Mori S; Yamaguchi M; Yasuhara M; Hori R
    Pharm Res; 1994 Jan; 11(1):60-4. PubMed ID: 8140057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANF disappearance and tissue distribution in rats.
    Widimsky J; Debinski W; Kuchel O; Buu NT
    Am J Physiol; 1990 Jan; 258(1 Pt 2):H134-9. PubMed ID: 2137296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic and renal effects of urodilatin bolus injections in patients with congestive heart failure.
    Kentsch M; Ludwig D; Drummer C; Gerzer R; Müller-Esch G
    Eur J Clin Invest; 1992 Oct; 22(10):662-9. PubMed ID: 1333960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit.
    Marleau S; Nguyen TT; Du Souich P; Bellemare M; De Lean A; Ong H
    Drug Metab Dispos; 1991; 19(1):194-9. PubMed ID: 1673398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolysis of iodine labelled urodilatin and ANP by recombinant neutral endopeptidase EC. 3.4.24.11.
    Abassi ZA; Golomb E; Agbaria R; Roller PP; Tate J; Keiser HR
    Br J Pharmacol; 1994 Sep; 113(1):204-8. PubMed ID: 7812611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic and renal effects of urodilatin in healthy volunteers.
    Kentsch M; Ludwig D; Drummer C; Gerzer R; Müller-Esch G
    Eur J Clin Invest; 1992 May; 22(5):319-25. PubMed ID: 1317296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4-23) in Doca-salt hypertensive rats.
    Vemulapalli S; Chiu PJ; Brown A; Griscti K; Sybertz EJ
    Life Sci; 1991; 49(5):383-91. PubMed ID: 1649942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EC 24.11 inhibition in man alters clearance of atrial natriuretic peptide.
    Richards AM; Wittert G; Espiner EA; Yandle TG; Frampton C; Ikram H
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1317-22. PubMed ID: 1827451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.